101 related articles for article (PubMed ID: 12639562)
1. Design, synthesis, and discovery of 5-piperazinyl-1,2,6,7-tetrahydro-5H-azepino[3,2,1-hi]indol-4-one derivatives: a novel series of mixed dopamine D2/D4 receptor antagonist.
Zhao H; Zhang X; Hodgetts K; Thurkauf A; Hammer J; Chandrasekhar J; Kieltyka A; Brodbeck R; Rachwal S; Primus R; Manly C
Bioorg Med Chem Lett; 2003 Feb; 13(4):701-4. PubMed ID: 12639562
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and discovery of 3-piperazinyl-3,4-dihydro-2(1H)-quinolinone derivatives: a novel series of mixed dopamine D2/D4 receptor antagonists.
Zhao H; Thurkauf A; Braun J; Brodbeck R; Kieltyka A
Bioorg Med Chem Lett; 2000 Sep; 10(18):2119-22. PubMed ID: 10999484
[TBL] [Abstract][Full Text] [Related]
3. Dopamine/serotonin receptor ligands. 13: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D(1)-D(5) receptors.
Enzensperger C; Lehmann J
J Med Chem; 2006 Oct; 49(21):6408-11. PubMed ID: 17034146
[TBL] [Abstract][Full Text] [Related]
4. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.
Zhao H; He X; Thurkauf A; Hoffman D; Kieltyka A; Brodbeck R; Primus R; Wasley JW
Bioorg Med Chem Lett; 2002 Nov; 12(21):3111-5. PubMed ID: 12372513
[TBL] [Abstract][Full Text] [Related]
5. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 1: identification and structure-activity relationships.
Zhao H; Thurkauf A; He X; Hodgetts K; Zhang X; Rachwal S; Kover RX; Hutchison A; Peterson J; Kieltyka A; Brodbeck R; Primus R; Wasley JW
Bioorg Med Chem Lett; 2002 Nov; 12(21):3105-9. PubMed ID: 12372512
[TBL] [Abstract][Full Text] [Related]
6. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
[TBL] [Abstract][Full Text] [Related]
7. Cyclic benzamides as mixed dopamine D2/serotonin 5-HT2 receptor antagonists: potential atypical antipsychotic agents.
Norman MH; Rigdon GC; Navas F; Cooper BR
J Med Chem; 1994 Aug; 37(16):2552-63. PubMed ID: 7914539
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands.
Li GC; Zhang BL; Xia JY; Fang ZJ
Pharmazie; 2015 Aug; 70(8):511-4. PubMed ID: 26380519
[TBL] [Abstract][Full Text] [Related]
9. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
[TBL] [Abstract][Full Text] [Related]
10. Fused azaindole derivatives: molecular design, synthesis and in vitro pharmacology leading to the preferential dopamine D3 receptor agonist FAUC 725.
Löber S; Hübner H; Gmeiner P
Bioorg Med Chem Lett; 2002 Sep; 12(17):2377-80. PubMed ID: 12161137
[TBL] [Abstract][Full Text] [Related]
11. A pharmacophore model for dopamine D4 receptor antagonists.
Boström J; Gundertofte K; Liljeforsa T
J Comput Aided Mol Des; 2000 Nov; 14(8):769-86. PubMed ID: 11131969
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
[TBL] [Abstract][Full Text] [Related]
13. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
[TBL] [Abstract][Full Text] [Related]
14. Extended N-Arylsulfonylindoles as 5-HT₆ Receptor Antagonists: Design, Synthesis & Biological Evaluation.
Vera G; Lagos CF; Almendras S; Hebel D; Flores F; Valle-Corvalán G; Pessoa-Mahana CD; Mella-Raipán J; Montecinos R; Recabarren-Gajardo G
Molecules; 2016 Aug; 21(8):. PubMed ID: 27537868
[TBL] [Abstract][Full Text] [Related]
15. A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agent.
Belliotti TR; Wustrow DJ; Brink WA; Zoski KT; Shih YH; Whetzel SZ; Georgic LM; Corbin AE; Akunne HC; Heffner TG; Pugsley TA; Wise LD
J Med Chem; 1999 Dec; 42(25):5181-7. PubMed ID: 10602703
[TBL] [Abstract][Full Text] [Related]
16. Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.
Löber S; Hübner H; Gmeiner P
Bioorg Med Chem Lett; 1999 Jan; 9(1):97-102. PubMed ID: 9990464
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-affinity relationship investigations of 5-heteroaryl-substituted analogues of the antipsychotic sertindole. A new class of highly selective alpha(1) adrenoceptor antagonists.
Balle T; Perregaard J; Ramirez MT; Larsen AK; Søby KK; Liljefors T; Andersen K
J Med Chem; 2003 Jan; 46(2):265-83. PubMed ID: 12519065
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor.
Austin NE; Avenell KY; Boyfield I; Branch CL; Hadley MS; Jeffrey P; Johnson CN; Macdonald GJ; Nash DJ; Riley GJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Wood MD
Bioorg Med Chem Lett; 2001 Mar; 11(5):685-8. PubMed ID: 11266169
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure-activity relationships, and molecular modeling studies of N-(indol-3-ylglyoxylyl)benzylamine derivatives acting at the benzodiazepine receptor.
Da Settimo A; Primofiore G; Da Settimo F; Marini AM; Novellino E; Greco G; Martini C; Giannaccini G; Lucacchini A
J Med Chem; 1996 Dec; 39(26):5083-91. PubMed ID: 8978839
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of potent and selective dopamine D(4) antagonists as candidate radioligands.
Huang Y; Kegeles LS; Bae S; Hwang D; Roth BL; Savage JE; Laruelle M
Bioorg Med Chem Lett; 2001 Jun; 11(11):1375-7. PubMed ID: 11378358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
